Elsevier

Antiviral Research

Volume 100, Issue 3, December 2013, Pages 605-614
Antiviral Research

Review
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research

https://doi.org/10.1016/j.antiviral.2013.09.028Get rights and content

Highlights

  • Host cell proteases activate the spike protein of the SARS-coronavirus.

  • Activation is essential for viral infectivity and a potential target for intervention.

  • Cathepsin L activates the spike protein in host cell endosomes.

  • TMPRSS2 activates the spike protein at the plasma membrane.

  • SARS- and MERS-coronavirus exploit the same proteases for activation.

Abstract

The severe acute respiratory syndrome (SARS) pandemic revealed that zoonotic transmission of animal coronaviruses (CoV) to humans poses a significant threat to public health and warrants surveillance and the development of countermeasures. The activity of host cell proteases, which cleave and activate the SARS-CoV spike (S) protein, is essential for viral infectivity and constitutes a target for intervention. However, the identities of the proteases involved have been unclear. Pioneer studies identified cathepsins and type II transmembrane serine proteases as cellular activators of SARS-CoV and demonstrated that several emerging viruses might exploit these enzymes to promote their spread. Here, we will review the proteolytic systems hijacked by SARS-CoV for S protein activation, we will discuss their contribution to viral spread in the host and we will outline antiviral strategies targeting these enzymes. This paper forms part of a series of invited articles in Antiviral Research on “From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses.’’

Keywords

SARS
Cathepsin L
TMPRSS2
Spike protein
Protease
MERS

Cited by (0)

View Abstract